Skip to content

Omeros OMER Senior Long Term Notes

Senior Long Term Notes at other companies

Opko Health logo
Opko HealthOPK
$246.64M+0.3%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:SeniorLongTermNotes.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's senior long term notes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's senior long term notes?
Omeros (OMER) reported senior long term notes of $52.81M in Q1 2026.
How has Omeros's senior long term notes changed year-over-year?
Omeros's senior long term notes decreased by 25.0% year-over-year, from $70.4M to $52.81M.
What is the long-term trend for Omeros's senior long term notes?
Over 5 years (2020 to 2025), Omeros's senior long term notes has grown at a -26.3% compound annual growth rate (CAGR), from $236.29M to $51.36M.
What does senior long term notes mean?
This represents the principal amount of senior debt securities with maturity dates exceeding one year. As senior debt, these obligations hold priority over other forms of debt and equity in the capital structure. Investors analyze this to evaluate the company's long-term leverage and its ability to manage significant debt maturities.